Abstract
Photosensitizers have recently been conjugated to nanobodies for targeted photodynamic therapy (PDT) to selectively kill cancer cells. The success of this approach relies on nanobody-photosensitizer conjugates that bind specifically to their targets with very high affinities (k D in low nM range). Subsequently, upon illumination, these conjugates are very toxic and selective to cells overexpressing the target of interest (EC 50 in low nM range). In this chapter, protocols are described to determine the binding affinity of the nanobody-photosensitizer conjugates and assess the toxicity and selectivity of the conjugates when performing in vitro PDT studies. In addition, and because the efficacy of PDT also depends on the (subcellular) localization of the conjugates at the time of illumination, assays are described to investigate the uptake and the intracellular degradation of the nanobody-photosensitizer conjugates.
Original language | English |
---|---|
Title of host publication | Photodynamic Therapy |
Subtitle of host publication | Methods and Protocols |
Editors | Mans Broekgaarden, Hong Zhang, Mladen Korbelik, Michael R. Hamblin, Michal Heger |
Publisher | Springer |
Chapter | 23 |
Pages | 505-520 |
Number of pages | 16 |
ISBN (Electronic) | 978-1-0716-2099-1 |
ISBN (Print) | 978-1-0716-2098-4 |
DOIs | |
Publication status | Published - 2022 |
Publication series
Name | Methods in Molecular Biology |
---|---|
Publisher | Humana Press |
Volume | 2451 |
ISSN (Print) | 1064-3745 |
Bibliographical note
Funding Information:The authors received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement No. 677582) and the Netherlands Organization for Scientific Research (NWO: Vici grant 016.140.657).
Publisher Copyright:
© 2022, Springer Science+Business Media, LLC, part of Springer Nature.
Keywords
- Binding affinity
- Co-cultures
- Intracellular degradation
- Nanobody-photosensitizer conjugate
- Selective toxicity
- Uptake